Share This

Public company info - Giant Biogene Holding Co. Ltd , 02367.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Giant Biogene Holding Co. Ltd, 02367.HK - Cash Flow 2021-12 2020-12 2019-12
Net Cash Flow from Operating Activities 910,658 955,258 715,962
Net Cash Flow from Return on Investments & Servicing of Finance -2,540,592 8,377 16,181
　Interest Received 9,408 9,882 16,181
　Interest Paid 0 0 0
　Dividend Received 0 0 0
　Dividend Paid -2,550,000 -1,505 0
　Others 0 0 0
Taxes (Paid) / Refunded -218,257 -121,134 -59,505
Net Cash Flow from Investing Activities 1,553,858 -531,001 -606,027
　Additions to Fixed Assets -111,061 -75,506 -114,725
　Disposal of Fixed Assets 16,528 0 0
　Increase in Investments -3,925,113 -5,084,378 -1,491,184
　Decrease in Investments 5,372,324 4,397,435 984,204
　Net Cash Flow with Related Parties 7,025,801 -16,018 -2,164
　Others -6,824,621 247,466 17,842
Net Cash Flow before Financing Activities -294,333 311,500 66,611
Net Cash Flow from Financing Activities 7,025,544 -16,018 -2,164
　New Loans 0 0 0
　Loans Repayment 0 0 0
　Fixed Income/Debt Instruments 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0
　Equity Financing 57 0 0
　Net Cash Flow with Related Parties 7,025,801 -16,018 -2,164
　Others -314 0 0
Increase(Decrease) in Cash & Cash Equivalents 6,731,211 295,482 64,447
Cash & Cash Equivalents at Beginning of Year 367,805 72,323 7,876
Net Cash Flow due to Change in Exchange Rate/Others 3,984 0 0
Cash & Cash Equivalents at End of Year 7,103,000 367,805 72,323
Currency Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.